Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration (FDA) Peripheral and...
Day: November 6, 2020
Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team...
Golden Leaf Holdings Announces Resignation of President Stanley Grissinger
CEO Jeff Yapp to assume role of President TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH)...
Braingrid Limited Announces Share Consolidation
TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”), is pleased to announce that...
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company...
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
Obalon Announces Third Quarter 2020 Financial Results
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the...
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to two new...
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Listing...
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
MONTREAL, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the...
Summit Announces Closing of Private Placement of $50 Million
Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million Cambridge, MA, November 6, 2020...
Premier Health Completes the Previously Announced Acquisition of Code Bleu
MONTRÉAL, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (formerly known as Physinorth Acquisition Corporation Inc.) (TSXV:...
Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for its Cannabis (CBD & CBG) Infused Chewing Gum Product Line
NOV 6 PR Complete Tauri-Gum™ Product Line (6 Flavors) The Recent Improvements to the U.S. Legal and Regulatory Landscape Have...
N.M. Medical Cannabis Program on Track to Break $200M Before Year End
Third-quarter patient sales up 62% over same period last year, COVID-19 continues to impact demand New Mexico Medical Cannabis Program...
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU
- Marked Reductions in Phe Observed at Two Doses - - Achieved Goal with Plans to Advance to Randomized, Concurrently...
Virbac : Declaration of the number of shares and voting rights October 2020
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...
Proof of Concept Controlled Phase 2 Clinical Trial Data Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson’s Disease Dementia Presented at CTAD 2020 Conference
Statistically significant improvements in CDR system Cognitive Domain of Attention assessed by Choice Reaction Time (p = 0.039) and Digital...
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020
Bagsværd, Denmark, 6 November 2020 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by...
Kannalife, Inc. Rebrands as Neuropathix, Inc. and Unveils New Ticker Symbol
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem...